Delivery Order SPE2DB22D2214-SPE2DB25FS3VC
Award Date
2/12/25
Potential Completion Date
2/13/25
Potential Value
$6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,079.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order to supply 4561065177 - PRILOSEC DR 10 MG SUSPENSION 30S, with a performance period through May 30, 2023. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with DLA Troop Support Medical, which...
This federal contract award, valued at $6,930.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order contract for the provision of Prilosec DR 2.5 MG Suspension 30S, a pharmaceutical product. The contract has a Firm Fixed Price pricing type and an ultimate completion date of February 6, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,708.16 firm fixed-price delivery order is for the supply of Prilosec DR 10 mg suspension to support military healthcare programs. The contract has an ultimate completion date of January 15, 2025 and is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
This federal contract award is for the delivery of PRILOSEC DR 2.5 MG SUSPENSION 30S pharmaceutical products to the Defense Logistics Agency (DLA). The $3,510.88 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as...
This federal contract award, valued at $1,386.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Prilosec DR 10 mg suspension, a prescription medication. This contract award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,722.17 firm fixed-price contract is for the supply of Prilosec DR 10 mg suspension medication, with a completion date of December 24, 2024. This contract is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This federal contract award, SPE2DX15D2105|SPE2DX23F7JC2, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $1,472.40 firm fixed price delivery order is for the supply of PRILOSEC DR 10 MG SUSPENSION 30S, a pharmaceutical product. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $3,594.28 for the supply of PRILOSEC DR 2.5 MG SUSPENSION 30S. The award was made by the Defense Logistics Agency (DLA), a defense agency, on January 31, 2024, with a completion date of February 1, 2024. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. The $1,278.20 firm fixed-price delivery order is for the supply of Prilosec DR 10 mg suspension products. The award does not have a set-aside designation, indicating it was made through full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award, with ID SPE2DB20D3101|SPE2DB23FRYE3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $25,395.84 firm-fixed-price delivery order is for the supply of Prilosec DR 10 mg suspension in 30-count packages. The contract has an ultimate completion date of September 20, 2023. The award was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug...